story of the week
Safety, Tolerability, and Efficacy of Zavegepant 10 mg Nasal Spray for the Acute Treatment of Migraine in the US
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Safety, tolerability, and efficacy of zavegepant 10 mg nasal spray for the acute treatment of migraine in the USA: a phase 3, double-blind, randomised, placebo-controlled multicentre trial
Lancet Neurol 2023 Mar 01;22(3)209-217, RB Lipton, R Croop, DA Stock, J Madonia, M Forshaw, M Lovegren, L Mosher, V Coric, PJ GoadsbyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.